Evaluation of orbital lesions with DCE-MRI: a literature review

References

• Qian W, Xu XQ, Hu H, Su GY, Wu JF, Shi HB, et al. Dynamic contrast-enhanced MRI in orbital lymphoproliferative disorders: effects of region of interest selection methods on time efficiency, measurement reproducibility, and diagnostic ability. J Magn Reson Imaging. 2018;47(5):1298–1305. doi:10.1002/jmri.25859.
   PubMed Web of Science ®Google Scholar
• Song L, Wang X, Guo J, Xian J. Quantitative analysis of dynamic contrast enhancement MRI between orbital lymphoma and inflammatory mass based on different regions of interest selection. Chin J Acad Radiol. 2020;3(1):41–49. doi:10.1007/s42058-020-00025-3.
   Google Scholar
• Sun B, Song L, Wang X, Li J, Xian J, Wang F, et al. Lymphoma and inflammation in the orbit: diagnostic performance with diffusion‐weighted imaging and dynamic contrast‐enhanced MRI. J Magn Reson Imaging. 2017;45(5):1438–1445. doi:10.1002/jmri.25480.
   PubMed Web of Science ®Google Scholar
• Xian J, Zhang Z, Wang Z, Li J, Yang B, Man F, et al. Value of MR imaging in the differentiation of benign and malignant orbital tumors in adults. Eur Radiol. 2010;20(7):1692–1702. doi:10.1007/s00330-009-1711-0.
   PubMed Web of Science ®Google Scholar
• Lemke AJ, Kazi I, Felix R. Magnetic resonance imaging of orbital tumors. Eur Radiol. 2006;16(10):2207–2219. doi:10.1007/s00330-006-0227-0.
   PubMed Web of Science ®Google Scholar
• O’Connor JP, Tofts PS, Miles KA, Parkes LM, Thompson G, Jackson A. Dynamic contrast-enhanced imaging techniques: cT and MRI. Br J Radiol. 2011;84(2):112–120. doi:10.1259/bjr/55166688.
   PubMed Web of Science ®Google Scholar
• Hennig J, Scheffler K, Laubenberger J, Strecker R. Time-resolved projection angiography after bolus injection of contrast agent. Magn Reson Med. 1997;37(3):341–345. doi:10.1002/mrm.1910370306.
   PubMed Web of Science ®Google Scholar
• Heye AK, Culling RD, Valdés Hernández Mdel C, Thrippleton MJ, Wardlaw JM. Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review. Neuroimage Clin. 2014;6:262–274. doi:10.1016/j.nicl.2014.09.002.
   PubMed Web of Science ®Google Scholar
• Gordon Y, Partovi S, Müller-Eschner M, Amarteifio E, Bäuerle T, Weber MA, et al. Dynamic contrast-enhanced magnetic resonance imaging: fundamentals and application to the evaluation of the peripheral perfusion. Cardiovasc Diagn Ther. 2014;4(2):147–164. doi:10.3978/j.issn.2223-3652.2014.03.01.
   PubMedGoogle Scholar
• Asaumi J, Yanagi Y, Hisatomi M, Matsuzaki H, Konouchi H, Kishi K. The value of dynamic contrast-enhanced MRI in diagnosis of malignant lymphoma of the head and neck. Eur J Radiol. 2003;48(2):183–187. doi:10.1016/S0720-048X(02)00347-9.
   PubMed Web of Science ®Google Scholar
• Padhani AR, Husband JE. Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies. Clin Radiol. 2001;56(8):607–620. doi:10.1053/crad.2001.0762.
   PubMed Web of Science ®Google Scholar
• Petralia G, Summers PE, Agostini A, Ambrosini R, Cianci R, Cristel G, et al. Dynamic contrast‑enhanced MRI in oncology: how we do it. Radiol Med. 2020;125(12):1288–1300. doi:10.1007/s11547-020-01220-z.
   PubMed Web of Science ®Google Scholar
• Macura KJ, Ouwerkerk R, Jacobs MA, Bluemke DA. Patterns of enhancement on breast MR images: interpretation and imaging pitfalls. Radiographics. 2006;26(6):1719–1734. doi:10.1148/rg.266065025.
   PubMed Web of Science ®Google Scholar
• Hu H, Xu XQ, Liu H, Hong XN, Shi HB, Wu FY. Orbital benign and malignant lymphoproliferative disorders: differentiation using semi-quantitative and quantitative analysis of dynamic contrast-enhanced magnetic resonance imaging. Eur J Radiol. 2017;88:88–94. doi:10.1016/j.ejrad.2016.12.035.
   PubMed Web of Science ®Google Scholar
• Ro SR, Asbach P, Siebert E, Bertelmann E, Hamm B, Erb-Eigner K. Characterization of orbital masses by multiparametric MRI. Eur J Radiol. 2016;85(2):324–336. doi:10.1016/j.ejrad.2015.11.041.
   PubMed Web of Science ®Google Scholar
• Sun B, Song L. Orbital malignant lesions in adults: multiparametric MR imaging. Jpn J Radiol. 2017;35(8):454–462. doi:10.1007/s11604-017-0653-8.
   PubMed Web of Science ®Google Scholar
• Xu XQ, Qian W, Ma G, Hu H, Su GY, Liu H, et al. Combined diffusion-weighted imaging and dynamic contrast-enhanced MRI for differentiating radiologically indeterminate malignant from benign orbital masses. Clin Radiol. 2017;72(10):903–e9. doi:10.1016/j.crad.2017.04.007.
   Web of Science ®Google Scholar
• Yang BT, Wang YZ, Wang XY, Wang ZC. Mesenchymal chondrosarcoma of the orbit: cT and MRI findings. Clin Radiol. 2012;67(4):346–351. doi:10.1016/j.crad.2011.10.004.
   PubMed Web of Science ®Google Scholar
• Yang BT, Wang YZ, Dong JY, Wang XY, Wang ZC. MRI study of solitary fibrous tumor in the orbit. Am J Roentgenol. 2012;199(4):506–511. doi:10.2214/AJR.11.8477.
   Web of Science ®Google Scholar
• Yuan Y, Kuai XP, Chen XS, Tao XF. Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of malignant from benign orbital masses. Eur J Radiol. 2013;82(9):1506–1511. doi:10.1016/j.ejrad.2013.03.001.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Shi J, Guo J, Yan F, Fu L, Xian J. Value of MR imaging in differentiation between solitary fibrous tumor and schwannoma in the orbit. Am J Neuroradiol. 2013;34(5):1067–1071. doi:10.3174/ajnr.A3340.
   PubMed Web of Science ®Google Scholar
• Jittapiromsak N, Hou P, Liu HL, Sun J, Schiffman JS, Chi TL. Dynamic contrast-enhanced MRI of orbital and anterior visual pathway lesions. Magn Reson Imaging. 2018;51:44–50. doi:10.1016/j.mri.2018.04.016.
   PubMed Web of Science ®Google Scholar
• Tofts PS, Parker GJM. DCE-MRI: acquisition and analysis techniques. In: Barker BP GX Zaharchuk G, eds. Clinical perfusion MR. Cambridge: Cambridge University Press; 2013: 58–74.
   Google Scholar
• Gaddikeri S, Gaddikeri RS, Tailor T, Anzai Y. Dynamic contrast-enhanced mr imaging in head and neck cancer: techniques and clinical applications. AJNR Am J Neuroradiol. 2016;37(4):588–595. doi:10.3174/ajnr.A4458.
   PubMed Web of Science ®Google Scholar
• Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999;10(3):223–232. doi:10.1002/(SICI)1522-2586(199909)10:3<223:AID-JMRI2>3.0.CO;2-S.
   PubMed Web of Science ®Google Scholar
• Lecler A, Balvay D, Cuenod CA, Marais L, Zmuda M, Sadik JC, et al. Quality-based pharmacokinetic model selection on DCE-MRI for characterizing orbital lesions. J Magn Reson Imaging. 2019;50(5):1514–1525. 2019/04/17. doi:10.1002/jmri.26747.
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407(6801):249–257. doi:10.1038/35025220.
   PubMed Web of Science ®Google Scholar
• Erb-Eigner K, Asbach P, Ro SR, Haas M, Bertelmann E, Pietsch H, et al. DCE-MR imaging of orbital lesions: diagnostic performance of the tumor flow residence time τ calculated by a multi-compartmental pharmacokinetic tumor model based on individual factors. Acta Radiol. 2019;60(5):643–652. 2018/08/18. doi:10.1177/0284185118795324.
   PubMed Web of Science ®Google Scholar
• Jittapiromsak N, Hou P, Williams MD, Chi TL. Orbital oncocytoma: evaluation with dynamic contrast-enhanced magnetic resonance imaging using a time-signal intensity curve and positive enhancement integral images. Clin Imaging. 2016;42:161–164. doi:10.1016/j.clinimag.2016.11.020.
   PubMed Web of Science ®Google Scholar
• Xian J, Zhang Z, Wang Z, Li J, Yang B, Chen Q, et al. Evaluation of MR imaging findings differentiating cavernous haemangiomas from schwannomas in the orbit. Eur Radiol. 2010;20(9):2221–2228. doi:10.1007/s00330-010-1774-y.
   PubMed Web of Science ®Google Scholar
• Ohtsuka K, Hashimoto M, Akiba H. Serial dynamic magnetic resonance imaging of orbital cavernous hemangioma. Am J Ophthalmol. 1997;123(3):396–398. doi:10.1016/s0002-9394(14)70137-0.
   PubMed Web of Science ®Google Scholar
• Tanaka A, Mihara F, Yoshiura T, Togao O, Kuwabara Y, Natori Y, et al. Differentiation of cavernous hemangioma from schwannoma of the orbit: a dynamic MRI study. Am J Roentgenol. 2004;183(6):1799–1804. doi:10.2214/ajr.183.6.01831799.
   PubMed Web of Science ®Google Scholar
• Wilms G, Raat H, Dom R, Thywissen C, Demaerel P, Dralands G, et al. Orbital cavernous hemangioma: findings on sequential Gd-enhanced MRI. J Comput Assist Tomogr. 1995;19(4):548–551. doi:10.1097/00004728-199507000-00007.
   PubMed Web of Science ®Google Scholar
• Missori P, Tarantino R, Delfini R, Lunardi P, Cantore G. Surgical management of orbital cavernous angiomas: prognosis for visual function after removal. Neurosurgery. 1994;35(1):34–38. doi:10.1227/00006123-199407000-00005.
   PubMed Web of Science ®Google Scholar
• Scheuerle AF, Steiner HH, Kolling G, Kunze S, Aschoff A. Treatment and long-term outcome of patients with orbital cavernomas. Am J Ophthalmol. 2004;138(2):237–244. doi:10.1016/j.ajo.2004.03.011.
   PubMed Web of Science ®Google Scholar
• Xu XQ, Hu H, Liu H, Wu JF, Cao P, Shi HB, et al. Benign and malignant orbital lymphoproliferative disorders: differentiating using multiparametric MRI at 3.0T. J Magn Reson Imaging. 2017;45(1):167–176. doi:10.1002/jmri.25349.
   PubMed Web of Science ®Google Scholar
• Xu XQ, Qian W, Hu H, Su GY, Liu H, Shi HB, et al. Histogram analysis of dynamic contrast-enhanced magnetic resonance imaging for differentiating malignant from benign orbital lymphproliferative disorders. Acta Radiol. 2019;60(2):239–246. doi:10.1177/0284185118778873.
   PubMed Web of Science ®Google Scholar
• Haradome K, Haradome H, Usui Y, Ueda S, Kwee TC, Saito K, et al. Orbital lymphoproliferative disorders (OLPDs): Value of MR Imaging for differentiating orbital lymphoma from benign OPLDs. Am J Neuroradiol. 2014;35(10):1976–1982. doi:10.3174/ajnr.A3986.
   PubMed Web of Science ®Google Scholar
• Young SM, Kim YD, Shin HJ, Imagawa Y, Lang SS, Woo KI. Lacrimal gland pleomorphic adenoma and malignant epithelial tumours: clinical and imaging differences. Br J Ophthalmol. 2019;103(2):264–268. doi:10.1136/bjophthalmol-2017-311538.
   PubMed Web of Science ®Google Scholar
• Wang Y, Song L, Guo J, Xian J. Value of quantitative multiparametric MRI in differentiating pleomorphic adenomas from malignant epithelial tumors in lacrimal gland. Neuroradiology. 2020;62(9):1141–1147. doi:10.1007/s00234-020-02455-3.
   PubMed Web of Science ®Google Scholar
• Li X, Wu X, Qian J, Yuan Y, Wang S, Ye X, et al. Differentiation of lacrimal gland tumors using the multi-model MRI: classification and regression tree (CART)-based analysis. Acta Radiol. 06 02, 2021;63:2841851211021039. doi:10.1177/02841851211021039.
   Web of Science ®Google Scholar
• Liu Y, Tao X, Shi H, Li K. MRI findings of solitary fibrous tumours in the head and neck region. Dentomaxillofac Radiol. 2014;43(3):20130415. doi:10.1259/dmfr.20130415.
   PubMed Web of Science ®Google Scholar
• Liu Y, Li K, Shi H, Tao X. Solitary fibrous tumours in the extracranial head and neck region: correlation of CT and MR features with pathologic findings. Radiol Med. 2014;119(12):910–919. doi:10.1007/s11547-014-0409-9. 2014/05/28
   PubMed Web of Science ®Google Scholar
• Tsuchiya M, Masui T, Otsuki Y, Sakahara H. Mesenchymal chondrosarcoma of the orbit: imaging features of CT and MRI. Br J Radiol. 2018;91(1090):20170579. doi:10.1259/bjr.20170579.
   PubMed Web of Science ®Google Scholar
• Warner EJ, Burkat CN, Gentry LR. Orbital fibrous histiocytoma mimicking cavernous hemangioma on dynamic contrast-enhanced MRA imaging. Ophthalmic Plast Reconstr Surg. 2013;29(1):3–5. doi:10.1097/IOP.0b013e31825412f7.
   Web of Science ®Google Scholar
• Ramey NA, Lucarelli MJ, Gentry LR, Burkat CN. Clinical usefulness of orbital and facial time-resolved imaging of contrast kinetics (TRICKS) magnetic resonance angiography. Ophthalmic Plast Reconstr Surg. 2012;26(5):361–368. doi:10.1097/IOP.0b013e318261161e.
   Web of Science ®Google Scholar
• Jackson A, O’Connor J, Thompson G, Mills S. Magnetic resonance perfusion imaging in neuro-oncology. Cancer Imaging. 2008;8(1):186–199. doi:10.1102/1470-7330.2008.0019.
   PubMed Web of Science ®Google Scholar
• Choyke PL, Dwyer AJ, Knopp MV. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging. 2003;17(5):509–520. doi:10.1002/jmri.10304.
   PubMed Web of Science ®Google Scholar
• Guo P, Liu Z, Yan F, Wang J, Wei L, Lv H, et al. Prediction of the response of ocular adnexal lymphoma to chemotherapy using combined pretreatment dynamic contrast-enhanced and diffusion-weighted MRI. Acta Radiol. 2016;57(12):1490–1496. doi:10.1177/0284185116631181.
   PubMed Web of Science ®Google Scholar
• Russo C, Strianese D, Perrotta M, Iuliano A, Bernardo R, Romeo V, et al. Multi-parametric magnetic resonance imaging characterization of orbital lesions: a triple blind study. Semin Ophthalmol. 2020;35(2):95–102. doi:10.1080/08820538.2020.1742358.
   PubMed Web of Science ®Google Scholar